For a patient with an abnormal mammogram and ultrasound suggesting a lesion who refuses a follow‑up visit and only wants a biopsy order, is it appropriate to place the biopsy order without a documented clinical encounter, or is a face‑to‑face (or telehealth) visit required?

A Face-to-Face or Telehealth Visit is Required Before Placing a Biopsy Order

You cannot safely place a biopsy order without a documented clinical encounter when imaging recommends biopsy for an abnormal mammogram and ultrasound. This is both a medical necessity and a medicolegal imperative, regardless of the patient's preference to skip the visit.

Why a Visit is Mandatory

Clinical Assessment Requirements

The ACR Appropriateness Criteria explicitly state that "any woman presenting with a palpable lesion should have a thorough clinical breast examination, usually by the referring clinician or by a specialist breast clinician" and that "the radiologist must also be able to establish concordance between an imaging finding and a clinically detected mass" 1. This clinical correlation is not optional—it's a fundamental component of proper breast evaluation.

Key clinical tasks that require a visit:

• Establish imaging-clinical concordance: You must determine whether the imaging finding corresponds to any palpable abnormality or clinical concern. The ACR guidelines emphasize that "negative imaging evaluation should never overrule a strongly suspicious finding on physical examination or vice versa" 1.

• Perform risk stratification: Document patient-specific factors that influence biopsy urgency and technique selection, including:

  • High-risk status (family history, genetic mutations, prior atypical hyperplasia)
  • Pregnancy plans or immunosuppression status
  • Comorbidities that might contraindicate biopsy 1

• Select appropriate biopsy guidance method: The guidelines specify that "if a lesion is seen equally well on mammography and US, US guidance is preferred because of patient comfort, efficiency, economy, absence of ionizing radiation, and sampling accuracy" 1. You cannot make this determination without reviewing the actual images and clinical context.

• Obtain informed consent: Discuss risks, benefits, alternatives, and expected outcomes of the biopsy procedure—a conversation that cannot be adequately documented without a visit.

Medicolegal Protection

The standard of care requires documentation of your clinical decision-making process. Simply placing an order without a visit creates multiple liability exposures:

• Abandonment of care: If you order a biopsy without seeing the patient and a delay or complication occurs, you have no documentation of your clinical reasoning or patient counseling.

• Missed malignancy liability: Research shows that even with negative imaging, 1.2% of clinically suspicious palpable abnormalities prove malignant 2. Without examining the patient, you cannot assess clinical suspicion level.

• Lack of informed consent documentation: Biopsy carries risks (bleeding, infection, false negatives). Without a visit, you have no record of discussing these with the patient.

What to Document at the Visit

Your clinical encounter must include:

1. Focused breast examination: Document whether you can palpate an abnormality, its characteristics (size, mobility, texture, skin changes), and whether it corresponds to the imaging finding location.

2. Review of imaging: Note the BI-RADS category and specific findings. The ACR criteria indicate that BI-RADS 4 ("suspicious abnormality") has a likelihood ratio of 125 for malignancy, while BI-RADS 5 ("highly suggestive of malignancy") has a likelihood ratio of 2200 3.

3. Risk assessment: Document factors that might influence urgency (high-risk patient, pregnancy plans, extreme anxiety) 1.

4. Biopsy plan specifics: Document whether image-guided core biopsy (preferred) versus FNA versus surgical biopsy is appropriate. Core biopsy is "superior to FNAB in terms of sensitivity, specificity, and correct histological grading" 1.

5. Informed consent discussion: Document that you explained the procedure, alternatives (including risks of observation), and expected timeline for results.

Common Pitfalls to Avoid

Do not:

• Place a "standing order" for biopsy based solely on radiology recommendations without clinical evaluation
• Assume that because imaging is abnormal, clinical examination adds no value—physical exam may reveal findings that change management 1
• Skip the visit because the patient is "low risk"—even young women with probably benign findings may warrant biopsy in specific circumstances 1

Critical exception: The only scenario where immediate biopsy without additional workup might be appropriate is when imaging shows a clearly benign correlate (lipoma, oil cyst, calcified fibroadenoma) that definitively explains the clinical concern 1. However, even in this case, you need a visit to document that the imaging finding corresponds to the patient's concern.

Practical Approach for This Patient

Offer telehealth if in-person visit is a barrier. During the visit:

1. Review the mammogram and ultrasound reports with the patient
2. Explain why biopsy is recommended based on the BI-RADS category
3. Discuss the biopsy procedure, guidance method, and timeline
4. Document informed consent
5. Place the biopsy order with appropriate guidance specifications

If the patient absolutely refuses the visit, document this refusal in detail, explain the risks of proceeding without clinical evaluation, and consider whether this represents a breakdown in the physician-patient relationship that requires transfer of care. You cannot be compelled to provide substandard care that exposes you to liability.